Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: Interim results from GARNET - A phase I, single-arm study

Ana Oaknin, Lucy Gilbert, Anna V. Tinker, Jubilee Brown, Cara Mathews, Joshua Press, Renaud Sabatier, David M. O'Malley, Vanessa Samouelian, Valentina Boni, Linda Duska, Sharad Ghamande, Prafull Ghatage, Rebecca Kristeleit, Charles Leath, Wei Guo, Ellie Im, Sybil Zildjian, Xinwei Han, Tao DuanJennifer Veneris, Bhavana Pothuri

Research output: Contribution to journal › Article › peer-review

144 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: Interim results from GARNET - A phase I, single-arm study'. Together they form a unique fingerprint.

Medicine & Life Sciences